X
Record #51891

Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Original paper date
Jan 17, 2019
Institution
Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway · Section of Clinical Immunology and Infectious Diseases, Department of Rheumatology, Dermatology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Norway · Institute of Clinical Medicine, University of Oslo, Oslo, Norway · Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway · Research Laboratory, Nordland Hospital, Bodø, and Faculty of Health Sciences, K.G. Jebsen TREC, University of Tromsø, Tromsø, Norway · Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway · Department of Immunology, Oslo University Hospital, and University of Oslo, Oslo, Norway · Department of Clinical Science, University of Bergen, Bergen, Norway · Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Open access
No
Article type
Clinical Study
Broad categories
(HSC) Medicine - Gastroenterology(HSC) Medicine - Immunology(HSC) Medicine - Pharmacology
Citation lifecycle

How this paper is being cited

Pre-retraction
37
Same day
0
Post-retraction
0
% post-retraction
0.0%
~7.3 citations/yr before retraction · ~0.0 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse